Compare GCTS & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GCTS | YI |
|---|---|---|
| Founded | 1998 | 2010 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Blank Checks | Retail-Drug Stores and Proprietary Stores |
| Sector | Finance | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.5M | 49.0M |
| IPO Year | N/A | N/A |
| Metric | GCTS | YI |
|---|---|---|
| Price | $1.17 | $7.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 9.0M | 68.8K |
| Earning Date | 11-12-2025 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,893,000.00 | ★ $1,908,028,152.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,184.40 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.90 | $2.48 |
| 52 Week High | $2.47 | $11.35 |
| Indicator | GCTS | YI |
|---|---|---|
| Relative Strength Index (RSI) | 50.92 | 76.08 |
| Support Level | $0.96 | $5.11 |
| Resistance Level | $1.84 | $5.57 |
| Average True Range (ATR) | 0.14 | 1.08 |
| MACD | 0.02 | 0.17 |
| Stochastic Oscillator | 23.16 | 51.10 |
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.